ストックスクリーナーアプリを入手
0.72
3.59%
-0.0403
前日終値:
$0.7603
開ける：
$0.75
24時間の取引高:
203.06K
Relative Volume:
0.81
時価総額：
$748.95K
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-82.50%
1か月 パフォーマンス:
-87.39%
6か月 パフォーマンス:
-98.58%
1年 パフォーマンス:
-99.14%
1日の値動き範囲:
$0.6879
$0.75
1週間の範囲:
$0.64
$0.9122
52週間の値動き範囲:
$0.64
$101.62
Psyence Biomedical Ltd Stock (PBM) Company Profile
PBM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PBM
Psyence Biomedical Ltd
|
0.7327 | 777.16K | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.14 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
751.58 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
818.35 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
360.51 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
341.10 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Psyence Biomedical Ltd (PBM) 最新ニュース
Psyence BioMed Announces Adjournment of Annual and Special Shareholder Meeting on January 22, 2026 - The Manila Times
Too few shareholders: Psyence BioMed postpones meeting to Feb. 12 - Stock Titan
Psyence Biomedical Calls January 22, 2026 Shareholder Meeting to Vote on Financials, Board and Share Consolidation - TipRanks
Psyence Biomedical sets Jan. 20 as effective date for reverse stock split - MSN
Psyence Biomedical postpones planned reverse stock split By Investing.com - Investing.com Nigeria
Psyence Biomedical announces postponement of reverse stock split effective date - TipRanks
Psyence Biomedical postpones planned reverse stock split - Investing.com
Psyence Biomedical Ltd. Announces Postponement of Reverse Stock Split Effective Date - Quiver Quantitative
Psyence BioMed Announces Postponement of Previously Announced Reverse Stock Split Effective Date - GlobeNewswire
Reverse stock split on hold: Psyence BioMed keeps PBM trading - Stock Titan
Why Psyence Biomedical Ltd. stock could benefit from AI revolutionConsumer Goods Stocks & Free Powerful Profit Generation - bollywoodhelpline.com
Psyence BioMed Sets January 20, 2026 Start Date for 1-for-6.25 Reverse Stock Split - TipRanks
Day Trade: Is RLAY forming a bullish divergenceJuly 2025 Snapshot & Weekly High Return Stock Forecasts - baoquankhu1.vn
Can Psyence Biomedical Ltd. outperform in the next rally2025 Volatility Report & Weekly Watchlist for Consistent Profits - bollywoodhelpline.com
Entry Recap: Will Psyence Biomedical Ltd benefit from rate cutsWeekly Loss Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Aug Technicals: Is Psyence Biomedical Ltd a top pick in the sectorJuly 2025 Reactions & Smart Money Movement Tracker - baoquankhu1.vn
Quarterly Recap: Whats the beta of Psyence Biomedical Ltd stockGap Down & Daily Technical Forecast Reports - baoquankhu1.vn
Psyence Biomedical Shares Set to Reverse Split on Tuesday, January 20th (NASDAQ:PBM) - Defense World
Breakout Move: Can LSI Industries Inc. benefit from deglobalizationPortfolio Gains Summary & Safe Capital Growth Tips - baoquankhu1.vn
Psyence Biomedical (PBM) Announces 1-for-6.25 Reverse Stock Split Effective January 20, 2026 - Intellectia AI
Psyence Biomedical announces 1-for-6.25 share consolidation By Investing.com - Investing.com Nigeria
1-for-6.25 split leaves Psyence BioMed with 1,022,177 shares outstanding - Stock Titan
Psyence Biomedical Ltd. Announces 1-for-6.25 Share Consolidation Effective January 20, 2026 - Quiver Quantitative
Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split - Chartmill
Aug Catalysts: Can Psyence Biomedical Ltd Equity Warrant outperform in the next rally2025 Support & Resistance & Precise Swing Trade Alerts - baoquankhu1.vn
Psyence Biomedical Board Backs 2026 Strategy and Potential Share Buyback Program - TipRanks
Psyence Biomedical Ltd. (NASDAQ:PBM) Short Interest Down 63.6% in December - Defense World
Psyence BioMed Approves 2026 Financial Strategy, Board Authorizes Share Buyback on Value Opportunity - The Manila Times
Why Psyence BioMed may buy its own shares while developing therapies - Stock Titan
How Psyence Biomedical Ltd. stock performs in weak economyJuly 2025 Selloffs & Risk Adjusted Buy and Sell Alerts - Улправда
What is the fair value of Psyence Biomedical Ltd. stock nowFit and Size Notes & lightweight options for faster days - ulpravda.ru
Comparing Compugen (NASDAQ:CGEN) & Psyence Biomedical (NASDAQ:PBM) - Defense World
Is Psyence Biomedical Ltd. stock attractive for hedge fundsWeekly Trade Report & Expert Curated Trade Setup Alerts - ulpravda.ru
Surprises Report: Will Psyence Biomedical Ltd. Equity Warrant stock gain from strong economyJuly 2025 Breakouts & Daily Price Action Insights - Улправда
Will Psyence Biomedical Ltd. stock benefit from infrastructure spendingJuly 2025 PostEarnings & Reliable Breakout Forecasts - Улправда
What valuation multiples suggest for Psyence Biomedical Ltd. Equity Warrant stockQuarterly Investment Review & Reliable Intraday Trade Alerts - ulpravda.ru
How currency fluctuations impact Psyence Biomedical Ltd. Equity Warrant stock2025 Trading Volume Trends & Low Volatility Stock Recommendations - ulpravda.ru
Can Psyence Biomedical Ltd. stock rebound after recent weaknessWeekly Trade Report & Reliable Intraday Trade Alerts - Улправда
Will Psyence Biomedical Ltd. Equity Warrant stock deliver consistent dividendsMarket Activity Recap & Weekly Breakout Watchlists - Улправда
Why Psyence Biomedical Ltd. Equity Warrant stock appeals to analystsWeekly Stock Analysis & Expert Verified Stock Movement Alerts - Улправда
How Psyence Biomedical Ltd. stock reacts to oil pricesWeekly Earnings Recap & Technical Confirmation Trade Alerts - Улправда
Psyence Biomedical Ltd.Ordinary Shares (NQ: PBM - FinancialContent
Psyence Biomedical announces milestone in natural ibogaine HCl production - TipRanks
Psyence Biomedical Ltd. Announces Board Changes - marketscreener.com
Psyence BioMed Achieves Milestone in Natural Ibogaine HCl Production and Strengthens Balance Sheet With No Debt and $12m Cash - The Manila Times
Published on: 2026-01-04 19:06:08 - earlytimes.in
Investment Recap: Why Psyence Biomedical Ltd Equity Warrant stock appeals to analystsCPI Data & Real-Time Market Sentiment Alerts - Bộ Nội Vụ
Gainers Report: Why Psyence Biomedical Ltd stock could benefit from AI revolutionSell Signal & Real-Time Chart Pattern Alerts - moha.gov.vn
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing - TMX Newsfile
Psyence Biomedical (NASDAQ:PBM) Trading Down 6.1% – Here’s Why - Defense World
Psyence Biomedical Ltd (PBM) 財務データ
Psyence Biomedical Ltd (PBM) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
2.67%
2.45%
大文字化:
|
ボリューム (24 時間):